Advances in the use of Janus kinase inhibitors

Current Opinion in Rheumatology · Published 2026-03-17 · DOI 10.1097/bor.0000000000001154

Authors being retrieved — see the publisher record. https://doi.org/10.1097/bor.0000000000001154

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Decoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implications · Current Opinion in Rheumatology · 2025 · Same journal
• Environmental and occupational contributors to autoimmune, inflammatory, and musculoskeletal rheumatic disease: a review of emerging evidence and clinical implications · Current Opinion in Rheumatology · 2025 · Same journal
• Unraveling the relationship between disordered sleep and systemic sclerosis outcomes · Current Opinion in Rheumatology · 2025 · Same journal
• Fueling fibrosis: metabolic dysregulation in systemic sclerosis · Current Opinion in Rheumatology · 2025 · Same journal
• Cholinergic anti-inflammatory pathway and vagus nerve stimulation in rheumatoid arthritis · Current Opinion in Rheumatology · 2026 · Same journal
• Digital monitoring in rheumatoid arthritis: remote assessment, wearables, and data-driven disease management · Current Opinion in Rheumatology · 2026 · Same journal
• Updates in juvenile dermatomyositis: pathogenesis and therapy · Current Opinion in Rheumatology · 2025 · Same journal
• Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management · Current Opinion in Rheumatology · 2025 · Same journal
• Advances in the diagnosis and treatment of Sjögren disease · Current Opinion in Rheumatology · 2025 · Same journal
• Vasculitis in autoinflammatory diseases · Current Opinion in Rheumatology · 2025 · Same journal